hero background

ChondroFiller® at the Liquid Cartilage

Injectable, Structural Regenerative Implant for Cartilage Care

Protect • Repair • Regenerate

← Back Home
How long is the preservation window in knee OCD

How long is the preservation window in knee OCD

The short answer on timing

Knee OCD does have a preservation window, but it is not a single countdown clock measured in weeks. The key window is the stable-lesion stage: before the osteochondral fragment becomes unstable or detaches. A 2024 evidence-based review and broader reviews describe treatment decisions as being driven mainly by stability on MRI and clinical assessment, rather than by symptom duration alone. In children and younger teenagers with open growth plates, that window is usually more forgiving, and stable lesions are often given a 3- to 6-month trial of joint-preserving care because healing remains plausible during that phase.

What the literature does not provide is one universal cut-off for when damage becomes irreversible. The more useful dividing line is stage-based: once MRI or the clinical picture suggests instability or early detachment, the odds of success with purely conservative treatment fall and operative preservation becomes more likely. That distinction matters because progression can lead to loose fragments and later joint damage, while juvenile stable lesions still show meaningful healing potential during an initial 3- to 6-month preservation trial.

How knee OCD is actually diagnosed

Diagnosis is less about attaching a label on MRI than deciding what stage the lesion is at. A 2024 review notes that the clinical picture often tracks with stability: earlier lesions more often cause activity-related pain, while swelling, catching or locking raise more concern for a more advanced problem. For that reason, consultants match the symptom history and examination to the scan, rather than treating imaging as a verdict on its own.

The imaging pathway is usually straightforward. Standard knee X-rays come first — commonly with multiple standard views — because they can show the lesion and its bony setting. MRI is the test that usually changes management: it helps define lesion size, the condition of the overlying cartilage and, above all, whether the fragment appears stable or unstable. Current reviews describe MRI as the key tool for treatment planning, because that stability judgement is what tells the team whether a preservation route is still realistic or whether the lesion is already moving towards an operative decision.

Free non-medical discussion

Not sure what to do next?

Book a Discovery Call

Information only · No medical advice or diagnosis.

What suggests the lesion is still stable

Clinicians use the word stable for a lesion in which the bone-and-cartilage segment still looks seated in place, rather than clearly lifting, loosening or separating. In the 2024 evidence-based review, this is the group most often considered for an initial joint-preserving non-operative attempt, especially in children and younger teenagers with open physes. A 12-year-old with open growth plates and mainly activity-related pain may therefore sit in a very different category from a 15-year-old whose lesion already looks less secure.

Several features tighten that window. A 2025 juvenile-knee review highlights age 14 years or older, knee effusion, and loss of range of motion as markers associated with instability, while swelling or mechanical symptoms also raise concern that the lesion is less likely to remain a straightforward non-operative case. Catching or locking does not prove the fragment has detached, but it does raise concern that it is less firmly attached and less likely to settle with simple protection alone. For that reason, stability is judged by combining the symptom pattern with MRI findings, not by either one in isolation.

What happens during the first 3 to 6 months

For most stable juvenile knee OCD lesions, the first preservation phase is an active 3- to 6-month trial rather than a period of simply seeing what happens. The 2024 evidence-based review describes non-operative care for open-physis patients as joint-protecting treatment: activity restriction, protected weight-bearing, and a gradual return only if the knee is settling. In clinic, the point of follow-up over those 3 to 6 months is fairly concrete — whether pain is becoming less intrusive, whether the knee is quieter in day-to-day loading, and whether repeat assessment shows the lesion is moving in the right direction rather than stalling.

The realistic expectation is improvement in many cases, not in all. Published evidence and reviews suggest that some stable juvenile lesions progress with non-operative treatment over the first 3 to 6 months, while others do not, particularly when symptoms suggest the lesion may be less quiet or less stable. So the key follow-up question is not simply whether time has passed. It is whether, by the next review, the lesion is becoming clinically calmer and showing imaging progression, or whether it is failing to progress despite a proper preservation attempt.

When delay becomes more risky

Delay becomes more consequential when knee OCD stops behaving like a contained lesion and starts behaving like a fragment. Imaging reviews describe a pathway from a focal subchondral-bone lesion to instability or detachment; once that happens, the piece may act as a loose body inside the knee rather than a segment that is still seated in place. At that point the problem is no longer just pain control. Further joint-surface damage becomes more plausible, and the downstream risk of premature osteoarthritis is part of the discussion. In practice, this shift is stage-based, not simply a matter of reaching a date on the calendar, and MRI is central to assessing whether that instability threshold has been crossed.

Management is also often less forgiving once physes are closed. Reviews note that skeletal maturity is an important determinant of treatment, with stable open-physis juvenile lesions more often given a preservation-first trial and unstable or non-healing lesions more often moving to surgery. Once MRI or the wider clinical picture suggests instability or partial detachment, treatment more often moves away from preservation-first care towards fixation or cartilage-restoration strategies. The aim is not to dramatise the diagnosis; it is to recognise that a worsening knee may be moving from a simpler preservation problem to a more complex cartilage one.

When to see a specialist

Earlier review is sensible when the knee is not settling in the usual way — particularly if there is swelling, catching, locking, loss of motion, or symptoms that keep returning with sport over weeks to months. In children and adolescents, persistent knee pain is usually assessed rather than simply played through, because juvenile lesions have the best chance of joint preservation while they are still in the stable phase, and features such as effusion, mechanical symptoms, or reduced movement can point towards a narrower window.

The specialist’s job is not just to confirm the label. Using the clinical picture, radiographs and often MRI, they decide whether the knee still fits a preservation-first plan, whether a lesion may need fixation, or whether a later cartilage-repair discussion becomes relevant after failed initial treatment. In skeletally mature patients, management may move sooner towards operative options because skeletal maturity changes the balance of treatment planning.

Separate from that triage decision

If cartilage-restoration expertise is needed later in the pathway, Liquid Cartilage™ is delivered in the UK at the London Cartilage Clinic on Harley Street; assessment can be booked via londoncartilage.com.

  1. [1] Osteochondritis Dissecans Lesions of the Knee: Evidence-Based Treatment. (2024). https://doi.org/10.5435/JAAOS-D-23-00494 https://doi.org/10.5435/JAAOS-D-23-00494

Frequently Asked Questions

  • It is not a fixed countdown. The useful window is while the lesion is stable, especially before it becomes unstable or detaches.
  • MRI helps judge lesion size, cartilage condition and, most importantly, whether the fragment is stable or unstable. That stability decision guides treatment.
  • Children and younger teenagers with open growth plates and stable lesions are most often given an initial joint-preserving trial.
  • The first 3 to 6 months usually involve activity restriction, protected weight-bearing and follow-up to see whether pain and imaging are improving.
  • Seek earlier review if there is swelling, catching, locking, loss of motion, or symptoms that keep returning over weeks to months.

Legal & Medical Disclaimer

This article is written by an independent contributor and reflects their own views and experience, not necessarily those of Liquid Cartilage. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.

Always seek personalised advice from a qualified healthcare professional before making decisions about your health. Liquid Cartilage accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.

If you believe this article contains inaccurate or infringing content, please contact us at [email protected].

Last reviewed: 2026For urgent medical concerns, contact your local emergency services.
Patient recovering with guidance

Take the Next Step

Cartilage damage won’t reverse on its own—yet with the right plan it can beprotected, repaired, and regenerated.

At Liquid Cartilage, you access world-leading science and a joint-preservation vision on Harley Street.

  • Start with a Discovery Call.
  • Or book your Consultation with Prof. Lee today.

(Consultation fee credited towards treatment if you proceed.)

Verified by DoctifyVerified by Doctify

Latest Blog

View all →
Which cartilage repair option fits your defect
26 May 2026

Which cartilage repair option fits your defect

Cartilage repair choice is driven first by defect size, joint and damage pattern: smaller isolated lesions tend towards OATS or scaffold-based repair, while larger symptomatic defects more often need AMIC, MACI or OCA. In the knee, MACI outperformed microfracture at 2 and 5 years for larger defects.

How long is the preservation window in knee OCD
26 May 2026

How long is the preservation window in knee OCD

Knee OCD has no single countdown clock; the preservation window is the stable-lesion stage before instability or detachment, with MRI and clinical assessment driving decisions. In children with open growth plates, stable lesions are often given a 3- to 6-month joint-preserving trial because healing remains plausible.

When Liquid Cartilage may be considered
24 May 2026

When Liquid Cartilage may be considered

Liquid Cartilage™ is considered for a defined symptomatic cartilage defect treated arthroscopically, not for diffuse joint wear: ChondroFiller™ is a cell-free type I collagen scaffold placed into the defect and sets into a hydrogel in about 3–5 minutes.

Early knee osteoarthritis and the preservation window
23 May 2026

Early knee osteoarthritis and the preservation window

Early knee osteoarthritis sits in a grey zone: X-rays can be normal or only mildly abnormal while cartilage, meniscal or bone-marrow damage is already present. A preservation window is usually still open in mild-to-moderate disease, but only after ruling out other causes of pain and stiffness.

When cartilage damage on scans needs action
21 May 2026

When cartilage damage on scans needs action

Cartilage damage on a scan matters most when it lines up with ongoing symptoms — persistent pain, recurrent swelling, catching, locking, giving way or lost movement — rather than as an isolated finding. Across the knee, hip and ankle, focal symptomatic defects usually need specialist assessment: a knee with a focal lesion on MRI that keeps swelling and clicking, a hip with deep groin pain and a labral tear that does not self-repair, or a painful or unstable talar lesion after injury all warrant review. Conservative care and watchful waiting can be enough when a lesion is stable and symptoms settle, particularly in children with nondisplaced talar lesions, but a defect that matches the clinical pattern rarely heals on its own.

ChondroFiller as a Breakthrough in Cartilage Repair
18 May 2026

ChondroFiller as a Breakthrough in Cartilage Repair

Discover the differences between traditional cartilage repair methods and the innovative ChondroFiller treatment for joint cartilage injuries. Traditional surgeries like debridement and microfracture promote fibrocartilage growth but involve longer recovery and potential durability issues. ChondroFiller, a minimally invasive cell-free collagen gel injection, supports natural hyaline-like cartilage regeneration with faster recovery and fewer complications. Clinical studies highlight ChondroFiller's safety, efficacy, and improved patient outcomes, making it an excellent option for moderate cartilage defects. Leading experts such as Professor Paul Lee at MSK Doctors guide personalized treatment choices, combining established and cutting-edge therapies for optimal joint restoration. Explore how emerging cartilage repair techniques are shaping the future of orthopaedics and enhancing patient mobility and quality of life.

Privacy & Cookies Policy